BBIO
NASDAQStockBridgeBio Pharma, Inc.
$68.82-2.76 (-3.87%)
52-Week Range
$30.14
$79.91
Key Stats
Market Cap
13.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.18
Volume
1.6M
Avg Volume
3.2M
Performance
1M
-6.20%
3M
-9.54%
6M
+32.08%
YTD
-13.11%
1Y
+108.59%
3Y
+367.86%
5Y
-2.73%
Price Chart
ETF Exposure
BBIO is held by 120 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| HELX | Franklin Genomic Advancements ETF | 4.18% |
| CANC | Tema Oncology ETF | 3.97% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 2.88% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 2.40% |
| BBP | Virtus Biotech ETF | 1.51% |
| FSML | Franklin Small Cap Enhanced ETF | 1.43% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 1.30% |
| XBI | State Street SPDR S&P Biotech ETF | 1.25% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 1.22% |
| IPO | Renaissance IPO ETF | 1.20% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 1.09% |
| IBB | iShares Biotechnology ETF | 1.06% |
| FPX | First Trust US Equity Opportunities ETF | 1.06% |
| PDP | Invesco Dorsey Wright Momentum ETF | 0.95% |
| IWO | iShares Russell 2000 Growth ETF | 0.93% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.91% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.82% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.80% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.77% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.77% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.74% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.73% |
| CVRT | Calamos Convertible Equity Alternative ETF | 0.72% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.71% |
| ILDR | First Trust Innovation Leaders ETF | 0.71% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.70% |
| FDMO | FIDELITY MOMENTUM FACTOR ETF | 0.66% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.57% |
| WDNA | WisdomTree BioRevolution Fund | 0.55% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.54% |
| SFYX | SoFi Next 500 ETF | 0.45% |
| VBK | Vanguard Small-Cap Growth ETF | 0.41% |
| IWM | iShares Russell 2000 ETF | 0.40% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.40% |
| VTWO | Vanguard Russell 2000 ETF | 0.39% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.37% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.37% |
| RSSL | Global X - Russell 2000 ETF | 0.35% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.35% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.33% |
| STXM | Strive Mid-Cap ETF | 0.33% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.31% |
| NXTI | Simplify NEXT Intangible Core Index ETF | 0.31% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.30% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.30% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.30% |
| UWM | ProShares - Ultra Russell2000 | 0.27% |
| SCHM | Schwab U.S. Mid-Cap ETF | 0.26% |
| PWS | Pacer WealthShield ETF | 0.26% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.25% |
Page 1 of 3Next
About BBIO ETF Exposure
BridgeBio Pharma, Inc. (BBIO) is held by 120 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.3B, BBIO is a widely held institutional stock. The stock currently trades at $68.82. Investors can gain exposure to BBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BBIO, sorted by portfolio weight.